Overview

Sign up for

Est.

1999

Fiscal Year Start

Jan 1

Organization Type

Grantseeker

AI Summary

The Myelodysplastic Syndromes Foundation (EIN: 22-3283911) is a nonprofit organization established by an international group of physicians and researchers to facilitate the ongoing exchange of information related to myelodysplastic syndromes (MDS), a type of cancer. With an operating budget of $2.6 million and total revenue of $2 million for the filing year 2024, the foundation is supported by multiple significant funders, none of which account for 50% or more of its revenue. More information can be found on their website, www.mds-foundation.org.

Mission Statement

ESTABLISHED BY AN INTERNATIONAL GROUP OF PHYSICIANS AND RESEARCHERS TO PROVIDE AN ONGOING EXCHANGE OF INFORMATION RELATING TO MDS.
Revenues
$2M
Expenses
$3M
Net Income:
-$951.7K
Assets
$3.8M
Liabilities
$257.7K
Net Assets:
+$3.6M
Operating Budget
$2.6M
Operating Budget by Year

Due Diligence

Are you a grantmaker?
Charity Verification Snapshot
IRS EO Business Master File Status
Listed as tax-exempt
IRS Pub 78 Status
Eligible for tax-deductible gifts
IRS Revocation Status
Not in Automatic Revocation of Exemption List
Go beyond basic verification
Instantly get 50+ financial health and governance metrics, including LUNA.
plg-image
plg-image
Go beyond basic verification
Instantly get 50+ financial health and governance metrics, including LUNA.
Total No. of Grants
8
Median grant size
$9.2K
Largest grant received
$27.3K
L
Lea Harrison
Board Member
D
DR Stephen Nimer
Board Member
D
DR Peter Greenberg
Board Member

Frequently Asked Questions

What is THE MYELODYSPLASTIC SYNDROMES FOUNDATION’s budget?
In 2024, THE MYELODYSPLASTIC SYNDROMES FOUNDATION reported an annual operating budget of around $2.6 million. More detailed financial information is available to registered users.
What causes does THE MYELODYSPLASTIC SYNDROMES FOUNDATION support?
THE MYELODYSPLASTIC SYNDROMES FOUNDATION supports work in Cancers.
Where does THE MYELODYSPLASTIC SYNDROMES FOUNDATION operate?
THE MYELODYSPLASTIC SYNDROMES FOUNDATION is headquartered in New York, NY.
Who funded THE MYELODYSPLASTIC SYNDROMES FOUNDATION recently?
In 2025, THE MYELODYSPLASTIC SYNDROMES FOUNDATION received grants from AMERICAN ONLINE GIVING FOUNDATION INC, FIDELITY INVESTMENTS CHARITABLE GIFT FUND, and Stanrose Foundation. More information on this organization’s funders is available to registered users.
What is the largest grant THE MYELODYSPLASTIC SYNDROMES FOUNDATION received in 2024?
The largest grant to THE MYELODYSPLASTIC SYNDROMES FOUNDATION in 2024 exceeds $27 thousand.